ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAYLodovico Terzi di Bergamo, Davide Rossi, Jui Wan Loh et al.|Hematological Oncology|2021Cited by 1